Clinical trials

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). The study will focus on participants who have active disease and are already taking standard of care…

Investigator

Michael R Bubb

Ages

18 Years - N/A

Sexes

All

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how safe and effective upadacitinib is in treating adult participants with moderately to severely active…

Investigator

Michael R Bubb

Ages

18 Years - 63 Years

Sexes

All